| abstract |
The invention concerns an isolated polypeptide comprising an amino acid sequence selected among the sequence SEQ ID n DEG 2 or n DEG 4, a sequence derived from or homologous with said sequence SEQ ID n DEG 2 or n DEG 4, or a biologically active fragment of said sequence SEQ ID n DEG 2 or n DEG 4, said isolated polypeptide being designated as "NEP II", and the use of said NEP II polypeptide for screening inhibitors useful in therapy. |